Health Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories October 27, 2026
Health Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance October 27, 2026
Health Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer October 26, 2026
Health ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026 October 26, 2026
Health Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) October 25, 2026
Health Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026 October 24, 2026
Health Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026 October 24, 2026
Health Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA October 23, 2026
Search
Health
October 27, 2026
October 27, 2026
October 27, 2026
October 26, 2026
October 26, 2026
October 26, 2026
October 25, 2026
October 24, 2026
October 24, 2026
October 23, 2026
